Category: Federal

Patient Groups Back Drugmakers in 340B Rebate Appeal, Without Disclosing Drug Industry Funding or Missed Compliance Deadline

July 29, 2025 William Newton, Associate Editor/Senior Writer Views

Three patient groups recently told a federal appeals court that a 340B rebate model “is essential to the effort to bring transparency to 340B.” One of those groups did not disclose its financial ties to drugmakers, and another is out of compliance with state public reporting laws.

Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions

July 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Alkermes is one of two drugmakers to recently announce new state exemptions to their 340B contract pharmacy restrictions.

Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Eisai, Vertex to Refund 340B Covered Entities for Overcharges

July 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Merck, Eisai and Vertex will refund 340B covered entities that purchased certain medications between 2022 and 2025, according to notices posted on HRSA's website.

Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Record Turnout for Fourth Annual ‘Defend 340B’ March on Capitol Hill

July 24, 2025 William Newton, Associate Editor/Senior Writer Views

340B advocates marched on Capitol Hill to "defend 340B" for the fourth straight summer. (Credit: Community Voices for 340B)

Nearly 80 advocates marched toward Capitol Hill yesterday in a record turnout for the fourth annual “Defend 340B March” in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Budget Reconciliation’s Effects Could Shape Efforts to Reform 340B, Policy Experts Say at 340B Coalition Conference

July 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

Tom O’Donnell (left) and Michael McCaughan (right) speak at the 340B Coalition Summer Conference in National Harbor, Md.

The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Analysis: How Medicaid Cuts in ‘Big Beautiful Bill’ Could Push Certain Hospitals Out of 340B and the Importance of Planning Ahead

July 24, 2025 William Newton, Associate Editor/Senior Writer Views

Experts warn that recently enacted Medicaid cuts could jeopardize some hospitals' 340B eligibility.

Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.

The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

OPA Director Touches on 340B Rebate Litigation and Other Key Matters at 340B Coalition Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Office of Pharmacy Affairs (OPA) Director Chantelle Britton addresses 340B stakeholders during remarks to open the 340B Coalition’s annual summer conference in National Harbor, Md. on Monday.

A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B PATIENTS Act Reintroduction Expected Soon, Hospital Trade Group Challenges Drug Industry Criticisms

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B Health President and CEO Maureen Testoni speaks at the 340B Coalition's Summer Conference in National Harbor, Md. on Monday.

The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

July 22, 2025 William Newton, Associate Editor/Senior Writer Views

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.

A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live